A Phase 3, Double Blind, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of Alfuzosin in Treating Men With ED and Mild LUTS.
Phase of Trial: Phase III
Latest Information Update: 03 Aug 2016
At a glance
- Drugs Alfuzosin (Primary)
- Indications Erectile dysfunction
- Focus Therapeutic Use
- 13 Feb 2012 Additional trial investigators identified as reported by ClinicalTrials.gov.
- 09 Feb 2012 Planned End Date changed from 1 Jun 2012 to 1 Jun 2013 as reported by ClinicalTrials.gov.
- 07 Jul 2011 Planned end date changed from 1 Jun 2011 to 1 Jun 2012 as reported by ClinicalTrials.gov.